Does that mean it could perhaps one day become an alternative to the widely used contrast agent gadolinium? This heavy metal has been used in clinics to detect tumors, inflammation, or vascular ...

We evaluated the safety and efficacy of motexafin gadolinium (MGd), a Trx inhibitor, as a single-agent therapy for metastatic RCC. Patients and Methods: Patients with metastatic RCC were infused ...

A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe ...

The QUANTI studies examined gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body weight, a gadolinium dose reduction of 60% compared to macrocyclic gadolinium-based contrast agents dosed at 0 ...

Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025: Berlin Thursday, February 27, 2025, 14:00 Hrs [IST] Bayer, a global leader in radiolog ...

The MRI contrast agents market is expected to grow 1.3X from 2022 to 2029, reaching USD 1.23 Billion by 2029. Paramagnetic ...

Bayer, a global leader in radiology, announced positive results from the Phase III study QUANTI CNS, which evaluated the investigational gadolinium-based contrast agent (GBCA) gadoquatrane in adults ...

[SMM Daily Review: Rare Earth Prices Fluctuated Slightly, Procurement Activities Remained Cautious] Today, rare earth market prices showed slight fluctuations. The price of Pr-Nd oxide rose to 443,000 ...